相关实验视频
Updated: Jul 7, 2025

06:08
Transcranial Pulse Stimulation for Alzheimer's Patients
Published on: April 4, 2025
641
深度大脑刺激作为阿尔茨海默病认知衰退的新兴疗法:证据和当前目标的系统审查
Bryce Picton1, Joey Wong2, Alexander M Lopez1
1Department of Neurological Surgery, University of California, Irvine, Orange, California, USA.
World neurosurgery
|December 23, 2023
概括
深度大脑刺激 (DBS) 可能会减缓阿尔茨海默病 (AD) 的认知衰退. 针对Meynert的和基底核 (NBM) 的研究表明有希望,但需要更大的试验才能对AD的DBS疗效得出明确的结论.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 医疗技术 医疗技术 医学技术
背景情况:
- 阿尔茨海默病 (AD) 目前缺乏治愈方法,需要治疗策略来减缓认知障碍.
- 深度大脑刺激 (DBS) 正在被探索为缓解AD症状的潜在干预措施.
- 本综述系统地评估了各种DBS目标的有效性,以减轻AD患者的认知衰退.
研究的目的:
- 系统地审查当前和以前的深度大脑刺激 (DBS) 目标的有效性,以减缓阿尔茨海默病 (AD) 的认知衰退.
主要方法:
- 使用PubMed,Scopus和Web of Science数据库进行了系统的文献审查.
- 包括1994年至2023年间发表的人类研究,记录样本大小,认知结果和并发症.
主要成果:
- 分析了14项涉及 (n=56),梅内尔特基底核 (NBM) (n=17) 和腹筋 (VS) (n=3) 的DBS的研究.
- 根据标准认知评估,在5/6个福尼克斯队伍和2/3个NBM队伍中,认知衰退减缓.
- 美国的DBS也表明,单一研究的下降速度有所放缓.
结论:
- 有证据表明,DBS对减缓AD认知衰退的潜在益处,特别是对fornix和NBM目标.
- 研究设计,结果测量和小队列大小的变化限制了关于AD的DBS实用性的最终结论.
- 进一步严格的研究是必不可少的,以确定DBS的安全性和有效性,作为阿尔茨海默病的治疗选择.
相关概念视频
Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
Brain Imaging
234
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
234
Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492

